| Cancer chemotherapy DL Gustafson, RL Page Withrow and MacEwen’s small animal clinical oncology, 157-179, 2013 | 688 | 2013 |
| NAD (P) H: quinone oxidoreductase 1: role as a superoxide scavenger D Siegel, DL Gustafson, DL Dehn, JY Han, P Boonchoong, LJ Berliner, ... Molecular pharmacology 65 (5), 1238-1247, 2004 | 560 | 2004 |
| A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients TW Flaig, DL Gustafson, LJ Su, JA Zirrolli, F Crighton, GS Harrison, ... Investigational new drugs 25, 139-146, 2007 | 402 | 2007 |
| Autophagy and cancer therapy A Thorburn, DH Thamm, DL Gustafson Molecular pharmacology 85 (6), 830-838, 2014 | 362 | 2014 |
| A study of high‐dose oral silybin‐phytosome followed by prostatectomy in patients with localized prostate cancer TW Flaig, M Glodé, D Gustafson, A van Bokhoven, Y Tao, S Wilson, LJ Su, ... The Prostate 70 (8), 848-855, 2010 | 235 | 2010 |
| Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non–small-cell lung cancer CD Thienelt, PA Bunn Jr, N Hanna, A Rosenberg, MN Needle, ME Long, ... Journal of Clinical Oncology 23 (34), 8786-8793, 2005 | 233 | 2005 |
| Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in … S McGrath, LR Bartner, S Rao, RA Packer, DL Gustafson Journal of the American Veterinary Medical Association 254 (11), 1301-1308, 2019 | 217 | 2019 |
| Continuous low‐dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs S Lana, L U'ren, S Plaza, R Elmslie, D Gustafson, P Morley, S Dow Journal of Veterinary Internal Medicine 21 (4), 764-769, 2007 | 213 | 2007 |
| Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD (P) H: quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition W Guo, P Reigan, D Siegel, J Zirrolli, D Gustafson, D Ross Cancer research 65 (21), 10006-10015, 2005 | 209 | 2005 |
| STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious P Maycotte, CM Gearheart, R Barnard, S Aryal, JM Mulcahy Levy, ... Cancer research 74 (9), 2579-2590, 2014 | 206 | 2014 |
| Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease ES Hackett, DC Twedt, DL Gustafson Journal of veterinary internal medicine 27 (1), 10-16, 2013 | 185 | 2013 |
| Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma RA Barnard, LA Wittenburg, RK Amaravadi, DL Gustafson, A Thorburn, ... Autophagy 10 (8), 1415-1425, 2014 | 184 | 2014 |
| Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and … S Leong, RB Cohen, DL Gustafson, CJ Langer, DR Camidge, K Padavic, ... Journal of clinical oncology 27 (26), 4413-4421, 2009 | 161 | 2009 |
| Assessment of the biological and pharmacological effects of the ανβ3 and ανβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors S Hariharan, D Gustafson, S Holden, D McConkey, D Davis, M Morrow, ... Annals of oncology 18 (8), 1400-1407, 2007 | 153 | 2007 |
| Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model DL Gustafson, JC Rastatter, T Colombo, ME Long Journal of pharmaceutical sciences 91 (6), 1488-1501, 2002 | 131 | 2002 |
| A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors M Basche, DL Gustafson, SN Holden, CL O'Bryant, L Gore, S Witta, ... Clinical Cancer Research 12 (18), 5471-5480, 2006 | 125 | 2006 |
| Quinone reductase inhibitors block SAPK/JNK and NFκB pathways and potentiate apoptosis JV Cross, JC Deak, EA Rich, Y Qian, M Lewis, LA Parrott, K Mochida, ... Journal of Biological Chemistry 274 (44), 31150-31154, 1999 | 122 | 1999 |
| Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology AK LeBlanc, M Breen, P Choyke, M Dewhirst, TM Fan, DL Gustafson, ... Science translational medicine 8 (324), 324ps5-324ps5, 2016 | 111 | 2016 |
| Enzymology of bioreductive drug activation. D Ross, HD Beall, D Siegel, RD Traver, DL Gustafson The British journal of cancer. Supplement 27, S1, 1996 | 110 | 1996 |
| Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. RS Yang, RS Thomas, DL Gustafson, J Campain, SA Benjamin, ... Environmental Health Perspectives 106 (suppl 6), 1385-1393, 1998 | 103 | 1998 |
